Aphelion Capital
Venture capitalSeed–Late Stage · 8 people tracked
Investment thesis
Aphelion Capital focuses on medical technologies and healthcare services that bring novel approaches to healthcare delivery. The firm backs companies aiming to improve clinical outcomes through entrepreneurial innovation, prioritizing exceptional teams united by a passion for their technology's vision. It emphasizes strong economics, investing in ideas that deliver better outcomes at the same or lower cost to the healthcare system while encouraging financial discipline. Beyond capital, Aphelion positions itself as a collaborative partner, offering portfolio companies meaningful support through an extensive network and active strategic limited partners to help build long-term success.
Source: firm website, verified Aug 2, 2026.
Team · 8 people
from the firm's websiteFrequently asked questions
- What stage does Aphelion Capital invest at?
- Aphelion Capital invests at the Seed, Series A, Series B, Late Stage stages.
- What sectors does Aphelion Capital focus on?
- Aphelion Capital focuses on Digital Health, Healthtech, Medical Devices.
Similar investors
Amadeus Capital Partners is a technology investor. It held a first close of $75M on its Amadeus IV Digital Prosperity Fund, focused on late-stage venture and growth companies building online and mobile services for emerging-market middle classes.
B Capital Group is a multistage venture capital firm that invests from seed to late stage, offering value-added support to founders in partnership with management consulting firm BCG.
Capricorn Venture Partners is a Belgium-based venture capital firm managing several funds across health, cleantech, digital, and fusion sectors, accepting pitches from companies raising capital.
DCVC (Data Collective) is a deep tech venture capital firm backing entrepreneurs using computational approaches to solve large real-world problems across many industries. It operates six flagship funds plus DCVC Bio, spanning 13 funds to date.
GV, originally launched as Google Ventures in 2009, is an independent venture capital firm with Alphabet as its sole limited partner. It invests from seed to growth stages across technology and life sciences and supports founders with operating partners and access to Google and Alphabet resources.